UNSPSC 85373502: Diagnosis of polymyositis

This classification denotes the group of activities that yields a diagnosis of Polymyositis. Polymyositis is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code M33. 2

UNSPSC 85373502 Diagnosis of polymyositis is a Commodity code that nominally names a specific medical diagnosis procedure, but the recent state and local opportunities posted under this code show little alignment with that scope. The three most recent solicitations—a diagnostic imaging PACS system from San Mateo Medical Center, ultrasound equipment from Collier County, Florida, and phlebotomy blood draw services from the Albuquerque Police Department—represent discrete clinical diagnostic or laboratory collection services rather than polymyositis diagnosis specifically. The code appears to be used as a catch-all for diagnostic services and equipment across multiple clinical domains, including radiology, cardiology, ultrasound imaging, and law-enforcement phlebotomy, suggesting that state and local procurement offices may be applying the code broadly to any diagnostic acquisition or service without narrowing to the specific myopathology diagnosis the code name implies.

The issuing bodies span county health systems, municipal police departments, and county-level procurement offices across California, Florida, and New Mexico, with no single repeat buyer evident in recent activity. The San Mateo Medical Center RFP (due August 7, 2026) is the largest and most detailed, seeking enterprise PACS implementation with EPIC EHR integration, 9–12 month implementation, and a five-year agreement term, with evaluation weighting 30 points to project approach, 25 points to firm qualifications, 20 points to team qualifications, and 25 points to price. The Collier County single-source notice for EchoNous ultrasound equipment and the Albuquerque Police Department RFB for phlebotomy technician services (due February 25, 2026) represent lower-complexity acquisitions. The code shows activity across three states but does not demonstrate strong concentration in any single jurisdiction or clinical domain.